3.4.17.23	COVID-19	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34445669&form=6&db=m	"Molecular Masks" for ACE2 to Effectively and Safely Block SARS-CoV-2 Virus Entry.	ongoing research,unassigned	3,0	
3.4.17.23	Severe Acute Respiratory Syndrome	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34445669&form=6&db=m	"Molecular Masks" for ACE2 to Effectively and Safely Block SARS-CoV-2 Virus Entry.	ongoing research,unassigned	3,0	
3.4.17.23	COVID-19	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33897423&form=6&db=m	1,2,3,4,6-Pentagalloyl Glucose, a RBD-ACE2 Binding Inhibitor to Prevent SARS-CoV-2 Infection.	causal interaction,diagnostic usage,therapeutic application,unassigned	3,1,4,0	
3.4.17.23	Virus Diseases	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33897423&form=6&db=m	1,2,3,4,6-Pentagalloyl Glucose, a RBD-ACE2 Binding Inhibitor to Prevent SARS-CoV-2 Infection.	causal interaction,diagnostic usage,therapeutic application,unassigned	3,1,4,0	
3.4.17.23	COVID-19	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33463909&form=6&db=m	17?-estradiol reduces SARS-CoV-2 infection in vitro.	causal interaction,unassigned	3,0	
3.4.17.23	Virus Diseases	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33463909&form=6&db=m	17?-estradiol reduces SARS-CoV-2 infection in vitro.	causal interaction,unassigned	3,0	
3.4.17.23	Prostatic Neoplasms	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20147525&form=6&db=m	1{alpha},25-Dihydroxyvitamin D3 inhibits growth of VCaP prostate cancer cells despite inducing the growth-promoting TMPRSS2:ERG gene fusion.	causal interaction,diagnostic usage,ongoing research,therapeutic application	4,1,2,2	
3.4.17.23	COVID-19	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33519467&form=6&db=m	3-Hydroxyphthalic Anhydride-Modified Chicken Ovalbumin as a Potential Candidate Inhibits SARS-CoV-2 Infection by Disrupting the Interaction of Spike Protein With Host ACE2 Receptor.	therapeutic application,unassigned	1,0	
3.4.17.23	Prostatic Neoplasms	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20534728&form=6&db=m	3beta-hydroxysteroid dehydrogenase is a possible pharmacological target in the treatment of castration-resistant prostate cancer.	causal interaction,ongoing research,therapeutic application,unassigned	3,1,4,0	
3.4.17.23	Prostatic Neoplasms	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23472063&form=6&db=m	5' UTR Control of Native ERG and of Tmprss2:ERG Variants Activity in Prostate Cancer.	causal interaction,unassigned	1,0